Evaluation of the AO Pediatric Classification for Long Bones Fractures Like a Guide for Treatment and Prognosis (AO-PC)

September 20, 2007 updated by: Hospital Cruz Roja Mexicana

Phase 2/3 Eficacy Study of the AO Pediatric Classification in Treatment and Prognosis of Long Bones Fractures

  1. Is the AO Pediatric classification for long bones fractures reproductible?
  2. Is the AO Pediatric Classification for long bones fractures a treatment guide?
  3. The AO pediatric Classification for long bones fractures could be a prognosis factor?

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

PROPOUSE:

  1. To determinate the efectivity of the AO pediatric classification for long bones fractures.
  2. To evaluate the functionality of the AO pediatric classification for long bones fractures.
  3. To analyze if the AO pediatric classification for long bones fractures is a prognosis factor

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Mexico
    • Federal District
      • Mexico City, Federal District, Mexico, 11510
        • Recruiting
        • Hospital Cruz Roja Mexicana, Delegacion Distrito Federal
        • Principal Investigator:
          • Jorge D Tejada-Hoyos, Resident
        • Sub-Investigator:
          • Carlos Torres-Castro, Resident
        • Sub-Investigator:
          • Eduardo A Caballero-Quirarte, MD Adscrit
        • Sub-Investigator:
          • Marcos R Muciño-Maldonado, MD Adscrit
        • Sub-Investigator:
          • Boris Ortuño-Numbela, MD Adscrit
        • Sub-Investigator:
          • Jesus E Rodriguez-Olguin, MD Adscrit
        • Sub-Investigator:
          • Jose L Rosas-Cadena, MD Adscrit
        • Sub-Investigator:
          • Jose Villaroel, MD Adscrit
        • Sub-Investigator:
          • Humberto L Vives-Aceves, MD Adscit
        • Sub-Investigator:
          • Alejandro Bello-González, TyO Chief

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 14 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Patients:

  • Less than 16 years old.
  • Open physis.
  • Long bone fractures.
  • X ray AP & lateral comparatives.
  • Informed consent for parents or tutor.
  • Don´t let the treatment during the time of study.

Exclusion Criteria:

  • Pathologic fractures.
  • Fractures not included en the AO pediatric classification for long bones.
  • Diseases that modifying the bone healing: Diabetes mellitus, osteogenesis imperfect, etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Defined Population
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1
Pediatric patients under 16 years old with long bones fractures
Procedure: clinical evaluation
analyze the x ray from each patient and evaluate the treatment y development of bone healing.
Other Names:
  • AO classification
Procedure: observational study
evaluate the walk patron, bone healing and range of motion at 1,3,6,12 months
Other Names:
  • AO clasification

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hospital Cruz Roja Mexicana

Investigators

  • Principal Investigator: Jorge D Tejada-Hoyos, M.D., orthopaedic resident

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2007

Study Completion (Anticipated)

July 1, 2008

Study Registration Dates

First Submitted

September 20, 2007

First Submitted That Met QC Criteria

September 20, 2007

First Posted (Estimate)

September 21, 2007

Study Record Updates

Last Update Posted (Estimate)

September 21, 2007

Last Update Submitted That Met QC Criteria

September 20, 2007

Last Verified

September 1, 2007

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CRM-2008-TYO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Children

Clinical Trials on clinical evaluation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe